go back

Tixagevimab and Cilgavimab Injection, 300 mg

Indiana rates for HCPCS Q0220

Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known SARS-CoV-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available COVID-19 vaccine is not recommended due to a history of severe adverse reaction to a COVID-19 vaccine(s) and/or COVID-19 vaccine component(s), 300 mg

Rates data updated July 2026.

Facilitymedian $63,096 · 10th–90th $63,096$70,7950%20%40%90th$63,096

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
CareSource
Setting
Facility
Modifier
Global
Typical Low
$63,095.73
Median
$63,095.73
Typical High
$70,794.58